Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06560866 · ClinicalTrials.gov registry record · NA
Disrupting SRFOH to Improve Substance Use and Mental Health Outcomes for Parents in Rural Regions
A NA study of Substance-Related Disorders, sponsored by Chestnut Health Systems.
- Recruiting
- Registry status
- NA
- Development phase
- 266
- Enrollment target
- 1
- Study location
NCT06560866: Recruiting NA study of Substance-Related Disorders, sponsored by Chestnut Health Systems.
NCT06560866 is a NA study of Substance-Related Disorders that is actively recruiting participants, run by Chestnut Health Systems. The registered enrollment target is 266 participants, below the 1,517-participant average among 58 other Substance-Related Disorders trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06560866, a NA study of Substance-Related Disorders, is actively recruiting participants, sponsored by Chestnut Health Systems.
- RECRUITING
- Registry status
- NA
- Development phase
- 266 participants
- Enrollment target
- 1
- Study location
Study Summary
The study will evaluate the effectiveness of the Just Care for Families program in preventing Oregon Department of Human Services (ODHS)-involved parents in rural communities from escalating opioid and/or methamphetamine use and mental health disorders by disrupting the associated social risk factors of health (SRFOH). In addition, investigators will examine the impacts of SRFOH on Just Care treatment and the associated costs from the perspective of provider clinics delivering Just Care. Just Care is a behavioral intervention for the treatment of parental substance abuse and child neglect for families involved in the child welfare system. Just Care involves treatment components, supported by ongoing purposeful engagement: (1) Substance use treatment; (2) Mental health treatment; (3) Parent management training; (4) Community building; (5) Systems Navigation; and (6) Addressing basic needs.
Primary Outcome
Changes in any opioid use in past 30 days as assessed by Addiction Severity Index opioid use items (heroin, methadone, and other).
Conditions Studied
Interventions
- BEHAVIORAL Just Care for Families
Study Locations (1)
Oregon
- Chestnut Health Systems - Eugene
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 266 participants |
| Start Date | 2023-11-24 |
| Est. Completion | 2028-01-30 |
| Phase | NA |
What NCT06560866 shows while recruiting
NCT06560866 is an interventional study that assigns participants to a tested intervention. The registered 266 participants enrollment target is mid-sized for trials with a published cap, below the 1,517-participant average among 58 other Substance-Related Disorders trials with a reported enrollment target (82% lower).
The record links to 1 condition, with Substance-Related Disorders appearing as the primary indexed condition, and to 1 intervention - of which Just Care for Families is the first listed.
NCT06560866 reports a single indexed study location in Oregon.
Frequently Asked Questions
What is clinical trial NCT06560866 about?
NCT06560866 is a clinical study titled "Disrupting SRFOH to Improve Substance Use and Mental Health Outcomes for Parents in Rural Regions". The study will evaluate the effectiveness of the Just Care for Families program in preventing Oregon Department of Human Services (ODHS)-involved parents in rural communities from escalating opioid and/or methamphetamine use and mental health disorders by disrupting the associated social risk factor...
What is the current status of trial NCT06560866?
This trial is currently recruiting. It is a NA study. The enrollment target is 266 participants. The study started on 2023-11-24. Estimated completion is 2028-01-30.
What conditions does trial NCT06560866 study?
This clinical trial studies the following conditions: Substance-Related Disorders.
What interventions are being tested in trial NCT06560866?
The interventions under investigation include: Just Care for Families (BEHAVIORAL).
Who is sponsoring clinical trial NCT06560866?
This trial is sponsored by Chestnut Health Systems, which has 20 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06560866 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Substance-Related Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06560866's enrollment target sits among peer trials
266 16th of 58 higher than 43 of 58 other Substance-Related Disorders trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Substance-Related Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Phase II: Scalable Digital Delivery of CRAFT Training for Professionals to Maximize Treatment Rates of OUD in Families
RECRUITING · NA
-
Feasibility of the 5-Step Method in the U.S.
RECRUITING · NA
-
Whole Health in VA Mental Health: Omnis Salutis
RECRUITING · NA
-
Expression of Stress Markers During Meth Treatment (EXPRESS+)
RECRUITING · NA
-
Improving Alcohol and Substance Use Care Access, Outcome, Equity During the Reproductive Years
RECRUITING · NA
-
Peer Recovery to Improve Polysubstance Use and Mobile Telemedicine Retention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05098652 · 266 participants · NA
Coaching Dementia Caregivers to Master Care-Resistant Behavior
- NCT06088277 · 266 participants · NA
Texting to Reduce Human Immunodeficiency Virus (HIV) Risk
- NCT06261814 · 266 participants · Phase 2
Contrast Enhanced Ultrasound to Evaluate Response to Chemoembolization in Patients With Liver Tumors
- NCT06312124 · 266 participants · NA
A Study of Opportunistic Salpingectomy to Prevent Ovarian Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI